Grants and Contributions:
Title:
YOUTH Project: Manufacturing and Regulatory Affairs
Agreement Number:
989182
Agreement Value:
$30,000.00
Agreement Date:
May 2, 2022 - Mar 10, 2023
Description:
This project will serve to advance Inversago’s CB1 inverse agonist development programs to provide new therapies aimed at improving the lives of patients affected by metabolic and fibrotic conditions.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Location:
Montreal, Quebec, CA H3B 4N4
Reference Number:
172-2022-2023-Q1-989182
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
821124369
Recipient Type:
For-profit organization
Recipient's Legal Name:
Inversago Pharma Inc
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Youth Employment Program
Program Purpose:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Coverage:
IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171